Tendencias Ahora
Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.
¿Ya eres miembro? Iniciar sesión
Onconetix, Inc. is a commercial stage biotechnology company. It is focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. It has Entadfi, a Food and Drug Administration approved, oral therapeutic for ... Onconetix, Inc. is a commercial stage biotechnology company. It is focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. It has Entadfi, a Food and Drug Administration approved, oral therapeutic for the treatment of benign prostatic hyperplasia (BPH), a disorder of the prostate, and Proclarix, an advanced proprietary diagnostic system for screening and diagnosis for men with indeterminate Prostate Specific Antigen (PSA) assessments in prostate cancer oncology. Entadfi is a once-daily, oral treatment for BPH that combines finasteride, a 5¿-reductase inhibitor, and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor. Proclarix is a next generation protein-based blood test that can be done with the same sample as a patient's regular PSA test. Proteomedix is seeking to develop diagnostic, prognostic, and predictive tools to enable cancer management at all stages of disease progression. Mostrar más
Período † | Variación(Ptos) | Variación % | Apertura | Precio Máximo | Precio Mínimo | Avg. Vol. diario | Precio Promedio Ponderado | |
---|---|---|---|---|---|---|---|---|
1 | -0.1089 | -32.4203632033 | 0.3359 | 0.34 | 0.21 | 803591 | 0.26625754 | CS |
4 | -0.393 | -63.3870967742 | 0.62 | 0.7 | 0.21 | 499753 | 0.40364643 | CS |
12 | -0.4041 | -64.0310568848 | 0.6311 | 2.11 | 0.21 | 10123128 | 0.63445242 | CS |
26 | -4.929 | -95.5973622964 | 5.156 | 6.5 | 0.21 | 4972316 | 1.04991514 | CS |
52 | -7.649 | -97.1178263078 | 7.876 | 21.4 | 0.21 | 6006883 | 5.45781686 | CS |
156 | -7.773 | -97.1625 | 8 | 21.4 | 0.21 | 5835738 | 6.37299889 | CS |
260 | -7.773 | -97.1625 | 8 | 21.4 | 0.21 | 5835738 | 6.37299889 | CS |
Parece que no se ha autenticado. Haga click al botón de abajo para iniciar la sesión y ver los símbolos recientemente consultados.
Soporte: (55) 4170 8128 | soporte@advfn.mx
Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones